In Canada, people with depression were allowed to use psychedelic mushrooms
Not only terminally ill patients can now undergo therapy with psychedelic and hallucinogenic mushrooms
Previously, the production, possession and sale of psychedelic mushrooms, also known as psilocybin, were illegal in Canada. Exceptions were made for terminally ill patients who could be prescribed such treatment. However, following the U.S. state of Oregon, which legalized the therapeutic use of this "drug, Canada has allowed the use of mushrooms for people suffering from various mental illnesses.
Mona Strelaeff, a 67-year-old woman living in Victoria, British Columbia, was the first patient to be treated with hallucinogenic mushrooms.
The woman had struggled for years with anxiety and depression related to remission from breast cancer and childhood trauma. Thanks to the new therapy, the woman was able to cope with painful memories.
"Our mission is to help Canadians in need get access to medical psilocybin," shares Spencer Hawkswell, CEO of TheraPsil. We started with palliative cases for a number of reasons. First, in Canada, you have the right to voluntarily pass away, so you should certainly have the right to try psilocybin. Second, not everybody has time to wait."
Recent clinical studies have shown that psilocybin is promising in the treatment of depression, anxiety and post-traumatic stress.
By January, TheraPsil intends to launch its first legal training program for physicians and therapists wishing to practice psychedelic therapy.
